Stock 688488 JIANGSU AIDEA PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Jiangsu Aidea Pharmaceutical Co., Ltd.

Equities

688488

CNE1000041S6

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 03:30:00 17/05/2024 am IST 		5-day change 1st Jan Change
15.4 CNY -1.09% Intraday chart for Jiangsu Aidea Pharmaceutical Co., Ltd. -5.29% +23.10%
25/04 Jiangsu Aidea Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
23/02 Jiangsu Aidea Pharmaceutical Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2023 2024 2025 2026
Capitalization 1 5,264 6,480 - -
Enterprise Value (EV) 1 5,264 6,480 6,480 6,480
P/E ratio -65.8 x - - -
Yield - - - -
Capitalization / Revenue - 11.8 x 7.52 x 5.69 x
EV / Revenue - 11.8 x 7.52 x 5.69 x
EV / EBITDA - - - -
EV / FCF - - - -
FCF Yield - - - -
Price to Book - 6.26 x 6.53 x 6.29 x
Nbr of stocks (in thousands) 4,20,783 4,20,783 - -
Reference price 2 12.51 15.40 15.40 15.40
Announcement Date 23/02/24 - - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2023 2024 2025 2026
Net sales 1 - 550 862 1,138
EBITDA - - - -
EBIT 1 - -111 -52 43
Operating Margin - -20.18% -6.03% 3.78%
Earnings before Tax (EBT) - - - -
Net income -81.3 - - -
Net margin - - - -
EPS -0.1900 - - -
Free Cash Flow - - - -
FCF margin - - - -
FCF Conversion (EBITDA) - - - -
FCF Conversion (Net income) - - - -
Dividend per Share - - - -
Announcement Date 23/02/24 - - -
1CNY in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2023 2024 2025 2026
Net Debt - - - -
Net Cash position - - - -
Leverage (Debt/EBITDA) - - - -
Free Cash Flow - - - -
ROE (net income / shareholders' equity) - -8.7% -4.3% 3.5%
ROA (Net income/ Total Assets) - - - -
Assets - - - -
Book Value Per Share 1 - 2.460 2.360 2.450
Cash Flow per Share 1 - -0.2500 -0.4200 -0.1100
Capex - - - -
Capex / Sales - - - -
Announcement Date 23/02/24 - - -
1CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
15.4
Average target price
-
Consensus

Chiffre d''affaires - Rate of surprise

Company calendar

Sector Biopharmaceuticals

1st Jan change Capi.
JIANGSU AIDEA PHARMACEUTICAL CO., LTD. Stock Jiangsu Aidea Pharmaceutical Co., Ltd.
+23.10% 907M
CSL LIMITED Stock CSL Limited
-2.32% 92.59B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
+3.68% 41.43B
BIOGEN INC. Stock Biogen Inc.
-11.45% 33.49B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
-19.56% 14.62B
INCYTE CORPORATION Stock Incyte Corporation
-9.03% 12.77B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-11.34% 11.58B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-43.53% 11.35B
SWEDISH ORPHAN BIOVITRUM AB Stock Swedish Orphan Biovitrum AB
+3.75% 8.97B
INNOVENT BIOLOGICS, INC. Stock Innovent Biologics, Inc.
-6.32% 8.3B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. 688488 Stock
  4. Financials Jiangsu Aidea Pharmaceutical Co., Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW